positively affect the company’s image with the public. However‚ if they did not decide to develop the drug‚ it could negatively affect their image especially if the media would be aware of it. Think about the decision in terms of the CSR pyramid. Did Merck have an ethical obligation to proceed with development of the drug? Would it matter if the drug had only a small chance to cure river blindness? Does it depend on how close the company was to achieving a cure‚ or how sure they were that they could
Premium Integrity Pharmaceutical drug Onchocerciasis
Introduction and Situational Analysis Merck and River Blindness ethical dilemma is whether to pursue research that may or may affect the profits‚ or to choose a safer choice and go for profit rather than researching the drug. The outcome from researching the drug could possibly lead to healing the deadly and dangerous disease known as River Blindness. This drug is known to kill the parasite that has caused the disease. The problem with this situation was that the consumers of the drug could not pay
Premium Pharmacology Medicine Ethics
Merck is a global research-driven pharmaceutical company dedicated to putting patients first. Merck’s highest priority areas are Alzheimer’s disease‚ atherosclerosis‚ cardiovascular disease‚ diabetes‚ novel vaccines‚ obesity‚ oncology‚ pain and sleep disorders. In addition‚ and importantly for licensing‚ the following other areas remain of high interest for focused investment in new compounds and mechanisms: antibiotics‚ antifungals‚ antivirals (HCV and HIV)‚ asthma‚ COPD‚ neurodegeneration‚ ophthalmology
Premium RNA Protein Immune system
3rd‚ 2014 Case 5: Merck‚ the FDA‚ and the Vioxx Recall Section I Merck was one of the world’s leading pharmaceutical firms. The company ranked 4th I sales after Pfizer and Johnson & Johnson and it ranked 5th in assets and market value. Merck ranked 1st in profits‚ earning $7.33 billion on $30.78 billion in sales. In 2006‚ Merck faced major challenges with their once best selling prescription painkillers‚ Vioxx which was pulled off the market in September of 2004 after Merck learned it increased
Free Pharmacology Food and Drug Administration
patent. In 1995‚ Merck entered into a licensed agreement and collaboration to hold the rights to market Gardisil in all countries accept Australia and New Zealand. Merck was invested heavily in Gardasil‚ spending $1.2 billion in fifteen years before seeking approval from the FDA. After results of all phase trials were impressive‚ Merck moved for FDA approval. Merck hoped to receive approval before a competitive drug‚ known as Cervarix was approved. If so‚ it would guarantee Mercks first mover advantage
Premium Human papillomavirus HPV vaccine Cervical cancer
pharmaceutical company. Its best-selling products include Lipitor‚ the world’s best- selling medicine‚ and eight of the top twenty-five medicines in the world. Acquisition of successful competitors such as Pharmacia and Warner Lambert has helped Pfizer to offer best-selling products and further differentiate itself from competitors. The acquisition of the latter company helped bring Lipitor under Pfizer’s control. Diverse packaging is needed to implement Pfizer’s strategy of a wide product offering
Premium Inventory Pharmaceutical industry Dividend yield
Contents Introduction "Workforce planning is about having the right talent with the right skills‚ at the right time and cost‚ to support the organization’s strategy. Workforce planning is a strategic response to changes in workforce demographics‚ business models and economic conditions – and in today’s environment‚ it’s more important than ever.” - Watson Wyatt Telecom’s industry is evolving at breakneck speed and the demands of the customer are forcing
Premium Human resource management Human resources
Merck (MRK) experienced only minute changes over the period that I held onto it. During this time‚ Merck experienced both positives and negatives‚ and these different experiences helped to balance the value of the company’s stock. At the beginning of the year‚ Merck successfully “acquired IOmet‚” a company that produces “innovative medicines for the treatment of cancer.” With this new subsidiary‚ Merck will most likely experience an increase in profits
Premium Balance sheet Financial ratios Generally Accepted Accounting Principles
The actions Merck undertook when marketing Vioxx and emphasizing its safety even after finding out the product’s side effects endangered all its key stakeholders and showed the real face of the company that accented its highly ethical maxims. Cardiovascular side effects of the Vioxx increased the risk of complications that could have caused patient’s death‚ therefore Merck violated the basic right to life of all the Vioxx consumers. It was already mentioned that Vioxx caused 3468 deaths by heart
Premium Enron Business ethics Ethics
The Case Against Merck and Co.‚ Inc. Chris Brefeld August 2‚ 2010 The Case of Merck and Co.‚ Inc. Merck and Co.‚ Inc. is one of the largest pharmaceutical companies in the world with a market capitalization of over $110 billion dollars. The company describes itself as a global research-driven pharmaceutical company that discovers‚ develops‚ manufactures‚ and markets vaccines and medicines to address unmet medical needs. The company also makes an effort to increase access to its medicine
Premium Atherosclerosis Pharmaceutical industry Clinical trial